Prognostic Significance of the Therapeutic Targets Histone Deacetylase 1, 2, 6 and Acetylated Histone H4 in Cutaneous T-Cell Lymphoma

Histopathology - United Kingdom
doi 10.1111/j.0309-0167.2008.03109.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley-Blackwell

Related search

Histone Deacetylase 6 (HDAC6); Histone Deacetylase 8 (HDAC8)

Science-Business eXchange
2013English

Histone Deacetylase Inhibitors Inhibit Metastasis by Restoring a Tumor Suppressive microRNA-150 in Advanced Cutaneous T-Cell Lymphoma

Oncotarget
Oncology
2016English

Histone Deacetylase 6 (HDAC6)

Science-Business eXchange
2010English

676 Exploring Novel Therapeutic Targets in the Treatment of Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Histone Deacetylase 2 (HDAC2)

Science-Business eXchange
2013English

Histone Deacetylase Inhibitors Modulate Interleukin 6-Dependent CD4+T Cell Polarizationin Vitroandin Vivo

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1beta -Induced Histone H4 Acetylation on Lysines 8 and 12

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

P062 Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Rheumatoid Arthritis

2019English

Structural Basis for Recognition of H3k56-Acetylated Histone H3–H4 by the Chaperone Rtt106

Nature
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy